InvestorsHub Logo
icon url

dinogreeves

02/27/17 11:08 PM

#1407 RE: Triple9 #1406

I think NMUS would be an ideal target. Did you also know that some big Pharma tried to acquire OWC$ above $2.00 per share and they declined the offer, which by the OWC$ has the same science as NMUS. I wouldn't know the exact metrics of the deal they have with the University, but I do know the University was given shares in exchange. I also think the studies in progress are too early too tell, much like OWC$. Hope it helps.